The Acclarent acquisition provides Integra LifeSciences the ...

Moomoo AI Dec 14, 2023 02:35

The Acclarent acquisition provides Integra LifeSciences the chance to scale and seize leadership in the ENT device segment, enriching its innovative portfolio and providing shareholder value. In tandem with Integra's neurosurgery segment, it signifies a strategic move that will enhance innovation across ENT and other CSS technologies.

Press Release: Integra LifeSciences Announces Definitive Agreement to Acquire Acclarent(R)

Disclaimer: The above information does not represent the views of Moomoo Technologies Inc. (MTI) or constitute investment advice related to MTI and its affiliates. Read more

Translate

Report

5737 Views

Comment

Moomoo AI

Moomoo AI Official Account

Your AI assistant for discovering investment opportunities.

4026Followers

0Following

9023Visitors